Sign inGet started

Jene Jill M.

Insider CIK 1742105 · LPCN Director · PDLI VP, Business Development

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LPCN Lipocine Inc. A Award deriv2026-06-032026-06-041,764$2.19 $3.9K8,938SEC↗
LPCN Lipocine Inc. A Award deriv2025-06-042025-06-051,764$3.20 $5.6K7,174SEC↗
LPCN Lipocine Inc. A Award deriv2024-06-052024-06-071,764$7.05 $12.4K5,410SEC↗
LPCN Lipocine Inc. A Award deriv2023-05-102023-05-1230,000$0.27 $8.1K62,000SEC↗
LPCN Lipocine Inc. A Award deriv2022-06-082022-06-1022,000$0.92 $20.2K32,000SEC↗
LPCN Lipocine Inc. A Award deriv2022-04-112022-04-1210,000$1.16 $11.6K10,000SEC↗
PDLI PDL BIOPHARMA, INC. A Award2020-01-082020-04-07194,805— $0194,805SEC↗
PDLI PDL BIOPHARMA, INC. A Award2020-01-082020-01-10194,805— $0194,805SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2019-03-282019-04-01377,358— $0377,358SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2019-03-282019-04-16384,615— $0384,615SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2018-09-252018-09-27377,358— $0377,358SEC↗